Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Efficacy Study of the Effect of Budesonide on Emphysema [Phase 4]
A Phase 4 efficacy study evaluating budesonide for emphysema associated with COPD has completed, sponsored by AstraZeneca.
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Evaluation of Symbicort® Turbuhaler® (Budesonide/Formoterol) in Chronic Obstructive Pulmonary Disease (COPD)
A clinical trial evaluating Symbicort Turbuhaler (budesonide/formoterol) in chronic obstructive pulmonary disease has completed. The sponsor…
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Airway Clearance Study [Phase 4]
Phase 4 Airway Clearance Study sponsored by AstraZeneca in chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Evaluation Of The Efficacy Of Corticosteroids In Patients With An Acute Exacerbation Of Chronic Obstructive Pulmonary Disease Receiving Ventilator Support [Phase 4]
Phase 4 trial evaluating corticosteroids for acute exacerbation of chronic obstructive pulmonary disease in ventilated patients has been ter…
-
CLINICAL_TRIALS trial_result · 2011-01-21Clinical Trial Update: Efficacy and Safety of Four Doses of Glycopyrronium Bromide (NVA237) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD), in Comparison to an Active Comparator Tiotropium [Phase 2]
Phase 2 trial evaluated four doses of glycopyrronium bromide (NVA237) versus the active comparator tiotropium in patients with stable COPD, …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-01-21Clinical Trial Update: Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease [Phase 2]
Phase 2 study evaluating safety and tolerability of 28 days of once-daily glycopyrronium bromide (NVA237) at 100 or 200 µg in moderate to se…
-
CLINICAL_TRIALS research · 2011-01-19Clinical Trial Update: Causes, Characteristics and Mechanisms of Infective Exacerbations in Subjects With Asthma and Chronic Obstructive Pulmonary Disease (COPD)
This clinical trial update reports on a completed study investigating the causes, characteristics, and mechanisms of infective exacerbations…
-
CLINICAL_TRIALS trial_result · 2011-01-06Clinical Trial Update: Effect of Salmeterol on Fluid Clearance From Alveolar-Capillary Membrane in COPD Patients [NA]
The document is a completed clinical trial update examining salmeterol's effect on alveolar-capillary fluid clearance in COPD patients; resu…
-
FDA approval · 2011-01-04FDA Approved: ADVAIR HFA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for ADVAIR HFA submitted by GlaxoSmithKline LLC.
-
FDA approval · 2011-01-04FDA Approved: ADVAIR DISKUS — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Advair Diskus submitted by GlaxoSmithKline LLC.
-
FDA approval · 2010-12-30FDA Approved: SEREVENT DISKUS — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for SEREVENT DISKUS (salmeterol xinafoate) submitted by GlaxoSmithKline LLC.
-
CLINICAL_TRIALS trial_result · 2010-12-29Clinical Trial Update: A Two Week Study to Assess the Tolerability of AZD9668 in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 2]
A Phase 2 trial evaluating tolerability of AZD9668 in chronic obstructive pulmonary disease has completed. Results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-12-24Clinical Trial Update: Vitamin D as Treatment for Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
A Phase 4 clinical trial evaluating vitamin D as a treatment for chronic obstructive pulmonary disease has completed.
-
FDA approval · 2010-12-23FDA Approved: ATROVENT HFA — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for Atrovent HFA (ipratropium bromide) from Boehringer Ingelheim Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2010-12-23Clinical Trial Update: A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
Phase 4 trial evaluating the effect of Advair Diskus 250/50 mcg on arterial stiffness in patients with chronic obstructive pulmonary disease…
-
CLINICAL_TRIALS trial_result · 2010-12-22Clinical Trial Update: Evaluation of Utility Quadriceps Magnetic Stimulation in COPD (Chronic Obstructive Pulmonary Disease) Patients After Hospital Exacerbation [Phase 3]
Phase 3 clinical trial evaluating quadriceps magnetic stimulation as a treatment for COPD following hospitalization due to a COPD exacerbati…
-
CLINICAL_TRIALS trial_result · 2010-12-21Clinical Trial Update: Cardiac Safety of Indacaterol [Phase 1]
A Phase 1 trial update reports on the cardiac safety of indacaterol, completed in healthy volunteers and patients with chronic obstructive p…
-
CLINICAL_TRIALS trial_result · 2010-12-15Clinical Trial Update: A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease [Phase 4]
Phase 4 study evaluating the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease; the tr…
-
FDA approval · 2010-12-10FDA Approved: ALBUTEROL SULFATE HFA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for Albuterol Sulfate HFA inhalation aerosol.
-
CLINICAL_TRIALS trial_result · 2010-12-10Clinical Trial Update: A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD). [Phase 4]
A 24-week Phase 4 trial in COPD evaluated safety and efficacy of Advair Diskus 250/50 mcg plus Spiriva HandiHaler versus Spiriva HandiHaler …
-
FDA approval · 2010-12-08FDA Approved: ALBUTEROL SULFATE HFA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for ALBUTEROL SULFATE HFA submitted by Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2010-12-06Clinical Trial Update: Tolerability/Safety and Efficacy of Inhaled AZD4818 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
Phase 2 trial evaluating tolerability, safety, and efficacy of inhaled AZD4818 in adults with moderate to severe COPD. Results were posted i…
-
CLINICAL_TRIALS trial_result · 2010-12-03Clinical Trial Update: Patient's Perception in Symptoms Related to Morning Activity Based on Chronic Obstructive Lung Disease
A completed AstraZeneca-sponsored trial assessing how COPD patients perceive morning-activity–related symptoms.
-
CLINICAL_TRIALS trial_result · 2010-12-02Clinical Trial Update: The Use of a Forecasting System for Predicting Exacerbations of COPD [EARLY_Phase 1]
An early-phase Phase 1 study sponsored by AstraZeneca evaluated a forecasting system to predict COPD exacerbations; the study is reported as…
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: The Efficacy and Safety of Salmeterol/Fluticasone Propionate vs Atropium/Albuterol in Patients COPD [Phase 4]
Phase 4 clinical trial comparing salmeterol/fluticasone propionate to ipratropium/albuterol in COPD to evaluate efficacy and safety.